Diagnoptics
Healthcare Services · Netherlands · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Aarhusweg 4-9, Groningen, Groningen, 972...Phone Number
+31 505890612Website
www.diagnoptics.comRevenue
$6.2 MillionIndustry
About Diagnoptics
Is Diagnoptics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Diagnoptics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Diagnoptics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Diagnoptics is spiking on competitors!
Click to see if Diagnoptics had a recent Job posting/layoffs
Product Launch: Get notified when Diagnoptics launches new products
Earning: See what the market has to say on Diagnoptics recently announced quarterly report
Check if Diagnoptics has recently received funding, and reach out quickly before it becomes old news!
Diagnoptics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Diagnoptics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Diagnoptics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Diagnoptics.
Diagnoptics Tech Stack
A closer look at the technologies used by Diagnoptics
Diagnoptics News & Media
Top Healthcare Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Diagnoptics
Diagnoptics specializes in the non-invasive assessment of cardiovascular risk and diabetes through its innovative AGE Reader technology. The company focuses on providing immediate and patient-friendly solutions for evaluating advanced glycation endproducts (AGEs), which are linked to chronic diseases like diabetes and cardiovascular disorders. Thei... Read More